Department of Information, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Traditional Chinese Medicine (TCM) Big Data Innovation Lab of Beijing Office of Academic Research, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Immunol. 2024 Aug 12;15:1420216. doi: 10.3389/fimmu.2024.1420216. eCollection 2024.
BACKGROUND: The emergence of nanotechnology has injected new vigor into vaccine research. Nanovaccine research has witnessed exponential growth in recent years; yet, a comprehensive analysis of related publications has been notably absent. OBJECTIVE: This study utilizes bibliometric methodologies to reveal the evolution of themes and the distribution of nanovaccine research. METHODS: Using tools such as VOSviewer, CiteSpace, Scimago Graphica, Pajek, R-bibliometrix, and R packages for the bibliometric analysis and visualization of literature retrieved from the Web of Science database. RESULTS: Nanovaccine research commenced in 1981. The publication volume exponentially increased, notably in 2021. Leading contributors include the United States, the Chinese Academy of Sciences, the "", and researcher Zhao Kai. Other significant contributors comprise China, the University of California, San Diego, Veronique Preat, the , and the National Natural Science Foundation of China. The USA functions as a central hub for international cooperation. Financial support plays a pivotal role in driving research advancements. Key themes in highly cited articles include vaccine carrier design, cancer vaccines, nanomaterial properties, and COVID-19 vaccines. Among 7402 keywords, the principal nanocarriers include Chitosan, virus-like particles, gold nanoparticles, PLGA, and lipid nanoparticles. Nanovaccine is primarily intended to address diseases including SARS-CoV-2, cancer, influenza, and HIV. Clustering analysis of co-citation networks identifies 9 primary clusters, vividly illustrating the evolution of research themes over different periods. Co-citation bursts indicate that cancer vaccines, COVID-19 vaccines, and mRNA vaccines are pivotal areas of focus for current and future research in nanovaccines. "candidate vaccines," "protein nanoparticle," "cationic lipids," "ionizable lipids," "machine learning," "long-term storage," "personalized cancer vaccines," "neoantigens," "outer membrane vesicles," " nanovaccine," and "biomimetic nanotechnologies" stand out as research interest. CONCLUSIONS: This analysis emphasizes the increasing scholarly interest in nanovaccine research and highlights pivotal recent research themes such as cancer and COVID-19 vaccines, with lipid nanoparticle-mRNA vaccines leading novel research directions.
背景:纳米技术的出现为疫苗研究注入了新的活力。近年来,纳米疫苗研究呈指数级增长,但对相关文献的综合分析却明显缺失。
目的:本研究利用文献计量学方法揭示纳米疫苗研究的主题演变和分布。
方法:使用 VOSviewer、CiteSpace、Scimago Graphica、Pajek、R-bibliometrix 和 R 包等工具,对从 Web of Science 数据库中检索到的文献进行文献计量分析和可视化。
结果:纳米疫苗研究始于 1981 年,发表量呈指数级增长,特别是在 2021 年。主要贡献者包括美国、中国科学院、“”和研究员赵凯。其他重要贡献者包括中国、加州大学圣地亚哥分校、Veronique Preat、“”和中国国家自然科学基金委员会。美国是国际合作的中心枢纽。资金支持在推动研究进展方面发挥着关键作用。高引文章的关键主题包括疫苗载体设计、癌症疫苗、纳米材料特性和 COVID-19 疫苗。在 7402 个关键词中,主要的纳米载体包括壳聚糖、病毒样颗粒、金纳米粒子、PLGA 和脂质纳米粒子。纳米疫苗主要用于解决包括 SARS-CoV-2、癌症、流感和 HIV 在内的疾病。共被引网络的聚类分析确定了 9 个主要聚类,生动地展示了不同时期研究主题的演变。共被引突发表明,癌症疫苗、COVID-19 疫苗和 mRNA 疫苗是当前和未来纳米疫苗研究的重点领域。“候选疫苗”、“蛋白纳米颗粒”、“阳离子脂质”、“离子化脂质”、“机器学习”、“长期储存”、“个性化癌症疫苗”、“新抗原”、“外膜囊泡”、“纳米疫苗”和“仿生纳米技术”是研究热点。
结论:本分析强调了学者对纳米疫苗研究日益浓厚的兴趣,并突出了最近的关键研究主题,如癌症和 COVID-19 疫苗,脂质纳米颗粒-mRNA 疫苗引领新的研究方向。
Hum Vaccin Immunother. 2024-12-31
Hum Vaccin Immunother. 2024-12-31
Front Public Health. 2022
Clin Exp Med. 2023-10
Hum Vaccin Immunother. 2021-8-3
Front Oncol. 2023-8-24
J Nanobiotechnology. 2023-8-2
Adv Healthc Mater. 2023-9
J Control Release. 2023-3